Antiandrogen-Equipped Histone Deacetylase Inhibitors Selectively Inhibit Androgen Receptor (AR) and AR-Splice Variant (AR-SV) in Castration-Resistant Prostate Cancer (CRPC)

Balaji Chandrasekaran, Subhasish Tapadar, Bocheng Wu, Uttara Saran, Ashish Tyagi, Alexis Johnston, David A. Gaul, Adegboyega K. Oyelere, Chendil Damodaran

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Antiandrogen-Equipped Histone Deacetylase Inhibitors Selectively Inhibit Androgen Receptor (AR) and AR-Splice Variant (AR-SV) in Castration-Resistant Prostate Cancer (CRPC)'. Together they form a unique fingerprint.

Medicine & Life Sciences